Rigel Pharmaceuticals, Inc. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

CASH, CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS (Tables)

CASH, CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS (Tables)

12 Months Ended

Dec. 31, 2019

CASH, CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS

Schedule of cash, cash equivalents and short-term investments

Cash, cash equivalents and short-term investments consist of the following (in thousands):


	December 31,
	2019		2018
Cash	$	3,371	$	2,626
Money market funds		7,457		9,106
U.S. treasury bills		12,539		—
Government-sponsored enterprise securities		19,017		7,872
Corporate bonds and commercial paper		55,694		108,933
	$	98,078	$	128,537
Reported as:
Cash and cash equivalents	$	22,521	$	76,322
Short-term investments		75,557		52,215
	$	98,078	$	128,537

Schedule of cash equivalents and short-term investments including the securities with unrealized gains and losses

Cash equivalents and short-term investments included the following securities with gross unrealized gains and losses (in thousands):


			Gross		Gross
	Amortized		Unrealized		Unrealized
December 31, 2019	Cost		Gains		Losses		Fair Value
U.S. treasury bills	$	12,532	$	8	$	(1)	$	12,539
Government-sponsored enterprise securities	$	19,010	$	8	$	(1)	$	19,017
Corporate bonds and commercial paper		55,685		14		(5)		55,694
Total	$	87,227	$	30	$	(7)	$	87,250

Schedule of contractual maturities of cash equivalents and short-term investments


			Gross		Gross
	Amortized		Unrealized		Unrealized
December 31, 2018	Cost		Gains		Losses		Fair Value
Government-sponsored enterprise securities	$	7,873	$	—	$	(1)	$	7,872
Corporate bonds and commercial paper		108,957		2		(26)		108,933
Total	$	116,830	$	2	$	(27)	$	116,805

Schedule of fair value and gross unrealized losses of the entity's investments in unrealized loss position

The following table shows the fair value and gross unrealized losses of our investments in individual securities that are in an unrealized loss position, aggregated by investment category (in thousands):


December 31, 2019	Fair Value		Unrealized Losses
U. S. treasury bills	$	4,512	$	(1)
Government-sponsored enterprise securities		8,009		(1)
Corporate bonds and commercial paper		18,731		(5)
Total	$	31,252	$	(7)